Acorda Therapeutics, Inc.
(NASDAQ : ACOR)

( )
ACOR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-1.65%88.151.3%$855.06m
AMGNAmgen Inc.
-2.71%186.701.2%$536.92m
BIIBBiogen Inc.
-4.48%216.711.3%$511.45m
ONCESpark Therapeutics, Inc.
-0.24%113.0011.2%$460.68m
GILDGilead Sciences, Inc.
-1.77%63.770.9%$455.57m
REGNRegeneron Pharmaceuticals, Inc.
-2.68%391.802.6%$275.42m
ILMNIllumina, Inc.
-3.26%308.793.5%$273.28m
VRTXVertex Pharmaceuticals Incorporated
-0.56%181.531.9%$235.95m
BPTHBio-Path Holdings, Inc.
18.94%21.98190.1%$220.64m
SRPTSarepta Therapeutics, Inc.
-3.47%122.2615.4%$207.36m
EXASExact Sciences Corporation
-3.28%89.0025.3%$185.14m
ALXNAlexion Pharmaceuticals, Inc.
-2.98%130.212.0%$179.59m
AAgilent Technologies, Inc.
-3.68%78.981.6%$135.89m
IONSIonis Pharmaceuticals, Inc.
-1.99%78.908.3%$104.26m
INCYIncyte Corporation
-2.00%85.342.5%$93.76m

Company Profile

Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its two main products are Ampyra and Zanaflex Capsules. The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury. The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.